CNS Healthcare
Private Company
Total funding raised: $65M
Overview
CNS Healthcare is a private, revenue-generating clinical research site network and services company. It provides clinical trial execution services for pharmaceutical sponsors and CROs, primarily in neuroscience (e.g., Alzheimer's, mental health, addiction) but also across a broad range of therapeutic areas. With a seasoned team of board-certified investigators and a multi-site operational footprint, the company positions itself as a patient-centric partner in late-stage clinical development, having contributed to the FDA approval of over 100 treatments.
Technology Platform
Integrated clinical trial execution infrastructure including a network of physical research clinics, a mobile clinic unit for decentralized trials, and operational systems for patient recruitment, screening, protocol administration, and data collection. Leverages telemedicine and standard clinical trial software (EDC, CTMS).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
CNS Healthcare competes in a fragmented market with other private clinical research sites, large site networks (e.g., CenExel, Science 37's site network), and academic medical centers. Its differentiation lies in its deep neuroscience/psychiatry investigator expertise, long operational history (since 1996), and a broad therapeutic reach beyond its core focus.